Related Experiment Video
Updated: Feb 19, 2026

08:12
Experimental Methods to Study Human Postural Control
Published on: September 11, 2019
10.1K
Perturbation-evoked potentials: Significance and application in balance control research
Jessy Parokaran Varghese1, Robert E McIlroy1, Michael Barnett-Cowan1
1Department of Kinesiology, University of Waterloo, 200 University Ave W, Waterloo, Ontario, N2L 3G1, Canada.
Neuroscience and Biobehavioral Reviews
|November 7, 2017
Summary
Cortical involvement in human balance control is evident through perturbation-evoked potentials (PEPs). The N1 component of PEPs, peaking around 90-160ms, is crucial for understanding balance reactions.
Area of Science:
- Neuroscience
- Human motor control
- Somatosensory processing
Background:
- Historically, balance control was attributed solely to subcortical structures.
- Recent research highlights significant cortical involvement in human balance reactions.
- Perturbation-evoked potentials (PEPs) demonstrate cortical processing of postural disturbances.
Purpose of the Study:
- To review and synthesize existing research on perturbation-evoked potentials (PEPs).
- To emphasize the characteristics and significance of the PEP N1 component.
- To discuss implications for future research on PEPs in various populations.
Main Methods:
- Literature review of seminal studies on PEPs.
- Analysis of PEP components, including P1, N1, P2, and N2 potentials.
- Focus on factors influencing PEP characteristics.
Main Results:
- PEPs are broadly distributed over fronto-centro-parietal areas, with maximal amplitude at FCz/Cz.
- PEPs consist of distinct positive and negative potentials (P1, N1, P2, N2) at specific latencies.
- PEP components are modulated by perturbation specifics, postural set, and psychological factors.
Conclusions:
- Cortical structures play a vital role in human balance control.
- The PEP N1 component is a key indicator of cortical processing during postural perturbations.
- Further research on PEPs is needed in both healthy individuals and patient populations.

